PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | | | | Mixed |
PHIP | Pleckstrin homology domain interacting protein | | | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
RPS6KB1 | Ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARRB1 | Arrestin, beta 1 | | | | | | Expressed in all |
IGF2BP2 | Insulin-like growth factor 2 mRNA binding protein 2 | Cytoskeleton related proteins Plasma proteins
| | | | | Mixed |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | | | | | | Expressed in all |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ATP6V1E2 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2 | | | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
GLUL | Glutamate-ammonia ligase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
HMGN3 | High mobility group nucleosomal binding domain 3 | | | | | | Expressed in all |
ITPR3 | Inositol 1,4,5-trisphosphate receptor, type 3 | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
KCNAB2 | Potassium voltage-gated channel, shaker-related subfamily, beta member 2 | Plasma proteins
| | | | | Expressed in all |
LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MARCKS | Myristoylated alanine-rich protein kinase C substrate | Plasma proteins
| | | | | Expressed in all |
NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PARP1 | Poly (ADP-ribose) polymerase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PC | Pyruvate carboxylase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | Enzymes
| | | | | Expressed in all |
PHPT1 | Phosphohistidine phosphatase 1 | | | | | | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets
| | | | | Expressed in all |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKAR2A | Protein kinase, cAMP-dependent, regulatory, type II, alpha | Plasma proteins
| | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
RAB31 | RAB31, member RAS oncogene family | | | | | | Expressed in all |
RPS6 | Ribosomal protein S6 | Ribosomal proteins
| | | | | Expressed in all |
S100A6 | S100 calcium binding protein A6 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
SIRT1 | Sirtuin 1 | | | | | | Expressed in all |